The path from understanding a disease to bringing a safe and effective new treatment to patients is lengthy and complex. Scientists work to piece together the basic causes of disease at the level of genes, proteins and cells.
The development of life science technologies typically involve long timelines and stringent regulatory hurdles, which in combination result in a high investment capital need. In contrast, the financial and societal reward can be tremendous in case of success.
This UNICO Practical Guide covers a selection of topics that are relevant to the management of technology transfer (TT) agreements and relationships.
While the IP Office recognizes that the specifics of any start-up company development may be unique, it has identified a number of common elements and the IP Office has developed standard mechanisms and support structures to assist with this process.
This document starts from the observation that in tandem with rapid advances in biotechnology research having valuable applications for use in healthcare the Canadian technology transfer activity has grown significantly.
In order to assist its researchers in providing this information, KU Leuven Research & Development (technology transfer office of KU Leuven) has developed a mandatory Patent Inventor Form.
Founded in 2001 as a wholly-owned subsidiary of the LifeScience Foundation, Ascenion is a technology transfer company focusing on the field of life sciences. It currently serves a total of 23 research institutes and university hospitals all over Germany.
PROvendis has its origins in the innovation consulting firm Zenit GmbH. Founded in 1984, ZENIT is a Public Private Partnership owned by the State of North Rhine- Westphalia, a consortium of banks and an association comprising some 180 enterprises.
Samples of human biological material are used for many purposes and are of increasing importance as the funders of research, whether public, charitable or commercial, prioritise areas which rely upon access to human biological samples.
Though the scale and substance of collaborations varies, a basic understanding of intellectual property rights (IPR) within the Chinese context may help to maximize the success of joint cooperation.
More and more innovation is driven by research collaborations between different entities. Within the context of globalized economy, these research and innovation collaborations are becoming increasingly internationalised.
This document is interesting reference document for those involved in negotiating and drafting agreements governing collaborations between research institutes.
Join our newsletter and get the latest news